Aspergillus flavus Infections in Children with Leukemia despite Liposomal Amphotericin-B Prophylaxis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Liposomal amphotericin-B (L-AmB) prophylaxis is used in children with leukemia when azoles are contraindicated, but its effect is debated. We reviewed cases of invasive aspergillosis despite L-AmB 2.5 mg/kg twice weekly in children with high-risk leukemia during 2012-2019. Ten (16%) of 62 children had proven or probable aspergillosis. Thus, L-AmB prophylaxis offered insufficient protection for Aspergillus, in particular for Aspergillus flavus.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Pediatric Infectious Disease Journal |
Vol/bind | 40 |
Udgave nummer | 8 |
Sider (fra-til) | 749-752 |
Antal sider | 4 |
ISSN | 0891-3668 |
DOI | |
Status | Udgivet - 2021 |
Bibliografisk note
Publisher Copyright:
© 2021 Wolters Kluwer Health, Inc. All rights reserved.
ID: 275774357